Research

FAU researchers presented their initial successes in their work for people suffering from myalgic encephalomyelitis/chronic fatigue syndrome. The researchers from Erlangen were able to prove that there are objectively measurable parallels between Long Covid and ME/CFS.

In recognition of our outstanding expertise in quantum research: a consortium consisting of eleven researchers from FAU will receive roughly three million euros in funding by 2025. The new lighthouse project Quantum Measurement and Control for the Enablement of Quantum Computing and Quantum Sensing will ignite basic research into quantum computing, sensing and imaging, combining physics and electrical engineering in new ways in the field of light and matter.

One of the rare diseases is hereditary spastic paraplegia, a disease that causes spasms and weakness in the leg muscles, increasingly affecting mobility as the disease progresses. Approximately 77,000 people across Europe suffer from the condition. Researchers have already discovered that the disease starts in nerve cells in the brain. These are obviously particularly difficult to investigate.

The Erlangen location of the Bavarian Center for Cancer Research (BZKF) is providing start-up funding worth a total of 110,000 euros to three research projects at Universitätsklinikum Erlangen. The aim of the projects is to conduct fundamental research into new therapeutic approaches for treating cancer.

Sport scientists have now discovered that long periods in space damage bone structure irreparably in some cases and can make parts of the human skeleton age prematurely by up to 10 years. Adapted training programs in conjunction with medication could provide better protection for astronauts on future space missions.

Researchers from the Museum für Naturkunde in Berlin and FAU have investigated extinction events with rapid global warming in the last 300 million years. They discovered that species from warm and cold waters are highly likely to become extinct as a consequence of global warming, while species in temperate waters survive.

At the current time, there is no cure for amyotrophic lateral sclerosis (ALS). Things may be about to change, however. Researchers at FAU and the University of California San Diego (UCSD) have identified a protein that already displays pathological characteristics at an early stage of the neurological disease.

With the Young Researcher Award (YRA) in Advanced Optical Technologies, the Erlangen Graduate School in Advanced Optical Technologies (SAOT) recognizes young researchers for their outstanding research and provides them with research funds and a guest professorship at FAU. This year, Samuel Grauer, PhD, received the YRA.